申请人:Sanofi, S.A.
公开号:US05618821A1
公开(公告)日:1997-04-08
Compounds of the formula ##STR1## wherein Q is chosen from the group consisting of pyridyl, pyrazyl, pyrimidyl, quinolyl, indolyl and 7-azaindolyl or any of these substituted with one or two substituents; Y is an alkylene bridge of 3-9 carbon atoms; R.sub.1 and R.sub.2 are each independently chosen from hydrogen, halo, alkyl, alkenyl, amino, alkylthio, hydroxy, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, alkoxy, nitro, carboxy, alkoxycarbonyl, dialkylaminoalkyl, alkylaminoalkyl, aminoalkyl, difluoromethyl, trifluoromethyl or cyano; R.sub.3 is alkoxycarbonyl, alkyltetrazolyl, substituted or unsubstituted phenyl or heterocyclyl, the N-oxide thereof, or a pharmaceutically acceptable acid addition salt thereof is an effective antipicornaviral agent.
公式为##STR1##的化合物,其中Q从吡啶基,吡唑基,嘧啶基,喹啉基,吲哚基和7-嗪啉基中选择,或者这些基团中的任何一个都被一个或两个取代基取代;Y是3-9个碳原子的烷基桥;R.sub.1和R.sub.2分别独立选择氢,卤素,烷基,烯基,氨基,烷硫基,羟基,羟基烷基,烷氧基烷基,烷硫基烷基,烷基亚磺酰基烷基,烷基磺酰基烷基,烷氧基,硝基,羧基,烷氧羰基,二烷基氨基烷基,烷基氨基烷基,氨基烷基,二氟甲基,三氟甲基或氰基;R.sub.3是烷氧羰基,烷基四唑基,取代或未取代的苯基或杂环基,其N-氧化物,或其药学上可接受的酸加合盐是有效的抗小肠病毒药物。